TherapeuticsMD, Inc.
TXMD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000025743
No open-market purchases or sales by TherapeuticsMD, Inc. insiders were filed in the last 90 days; 44 institutions reported holding it in 13F filings for Q2 2026, worth $8.10M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in TherapeuticsMD, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −6 vs. Q2 2023
- Shares held
- 2.99M
- −43.6K (−1.4%) vs. Q2 2023
- Total value
- $9.02M
- −$3.47M (−27.8%) vs. Q2 2023
- New holders
- 4
- 7 more added
- Sold out
- 10
- 6 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TXMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 44 | $8.10M |
| Q1 2026 | 49 | $7.94M |
| Q4 2025 | 44 | $5.52M |
| Q3 2025 | 46 | $3.54M |
| Q2 2025 | 42 | $3.78M |
| Q1 2025 | 42 | $3.09M |
| Q4 2024 | 41 | $3.03M |
| Q3 2024 | 37 | $5.61M |
| Q2 2024 | 38 | $5.49M |
| Q1 2024 | 43 | $7.73M |
| Q4 2023 | 39 | $7.32M |
| Q3 2023 | 36 | $9.02M |
| Q2 2023 | 42 | $12.5M |
| Q1 2023 | 41 | $11.7M |
| Q4 2022 | 44 | $19.4M |
| Q3 2022 | 43 | $13.8M |
| Q2 2022 | 53 | $20.3M |
| Q1 2022 | 125 | $40.4M |
| Q4 2021 | 132 | $44.1M |
| Q3 2021 | 150 | $98.2M |
| Q2 2021 | 155 | $203.9M |
| Q1 2021 | 162 | $237.0M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding TherapeuticsMD, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Aspire Private Capital, LLC | 1 | $3 | 0.00% | 00.0% | Unchanged |
| Guardian Wealth Management, Inc. | 2 | $6 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 2 | $6 | 0.00% | +2 | New |
| Harbour Investments, Inc. | 8 | $24 | 0.00% | 00.0% | Unchanged |
| Focused Wealth Management, Inc | 16 | $48 | 0.00% | 00.0% | Unchanged |
| Provenance Wealth Advisors, LLC | 20 | $60 | 0.00% | +20 | New |
| Legacy Financial Group LLC | 100 | $302 | 0.00% | +100 | New |
| Huntington National Bank | 120 | $362 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 140 | $422 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 246 | $743 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 251 | $756 | 0.00% | −3,286−92.9% | Reduced |
| JPMorgan Chase & Co | 313 | $945 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 330 | $996 | 0.00% | −25−7.0% | Reduced |
| UBS Group AG | 697 | $2.10K | 0.00% | −1,675−70.6% | Reduced |
| National Bank of Canada | 720 | $2.11K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 939 | $2.84K | 0.00% | +644+218.3% | Added |
| Banque Cantonale Vaudoise | 1,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,694 | $8.00K | 0.00% | +1,612+149.0% | Added |
| FMR LLC | 8,292 | $25.0K | 0.00% | +30.0% | Added |
| Bank of America Corp | 8,510 | $25.7K | 0.00% | +8,110+2,027.5% | Added |
| Dimensional Fund Advisors LP | 10,154 | $30.7K | 0.00% | +10,154 | New |
| J. Goldman & Co LP | 13,562 | $41.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna Fundamental Investments, LLC | 15,619 | $47.2K | 0.00% | −7,954−33.7% | Reduced |
| Northern Trust Corp | 16,491 | $49.8K | 0.00% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 22,496 | $67.9K | 0.00% | +16+0.1% | Added |
| Sanders Morris Harris LLC | 25,000 | $75.5K | 0.02% | 00.0% | Unchanged |
| State Street Corp | 30,128 | $91.0K | 0.00% | 00.0% | Unchanged |
| Gabelli Funds LLC | 31,000 | $93.6K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 42,000 | $126.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 84,788 | $256.1K | 0.00% | +3,007+3.7% | Added |
| Morgan Stanley | 133,144 | $402.1K | 0.00% | −584−0.4% | Reduced |
| BlackRock Inc. | 136,505 | $412.2K | 0.00% | −622−0.5% | Reduced |
| Tejara Capital Ltd | 369,594 | $1.12M | 0.63% | 00.0% | Unchanged |
| Vanguard Group Inc | 385,248 | $1.16M | 0.00% | 00.0% | Unchanged |
| Clearline Capital LP | 455,388 | $1.38M | 0.14% | +160.0% | Added |
| Rubric Capital Management LP | 1,192,191 | $3.60M | 0.15% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −52,726−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −121−100.0% | Sold out |
| WealthPLAN Partners, LLC | 0 | $0 | 0.00% | −95−100.0% | Sold out |
| Cedar Mountain Advisors, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Private Trust Co NA | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Safeguard Financial, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |